Logo image of MYSE

MYSEUM INC (MYSE) Stock Fundamental Analysis

NASDAQ:MYSE - US23816M2061 - Common Stock

1.858 USD
-0.1 (-5.2%)
Last: 9/3/2025, 3:34:31 PM
Fundamental Rating

2

Overall MYSE gets a fundamental rating of 2 out of 10. We evaluated MYSE against 280 industry peers in the Software industry. MYSE has a great financial health rating, but its profitability evaluates not so good. MYSE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MYSE had negative earnings in the past year.
In the past year MYSE has reported a negative cash flow from operations.
In the past 5 years MYSE always reported negative net income.
In the past 5 years MYSE always reported negative operating cash flow.
MYSE Yearly Net Income VS EBIT VS OCF VS FCFMYSE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

MYSE's Return On Assets of -64.54% is on the low side compared to the rest of the industry. MYSE is outperformed by 86.43% of its industry peers.
The Return On Equity of MYSE (-52.17%) is worse than 69.64% of its industry peers.
Industry RankSector Rank
ROA -64.54%
ROE -52.17%
ROIC N/A
ROA(3y)-100.23%
ROA(5y)-97.03%
ROE(3y)-98.69%
ROE(5y)-103.79%
ROIC(3y)N/A
ROIC(5y)N/A
MYSE Yearly ROA, ROE, ROICMYSE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for MYSE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MYSE Yearly Profit, Operating, Gross MarginsMYSE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 -200K -400K -600K -800K -1M

More info and screens

7

2. Health

2.1 Basic Checks

MYSE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MYSE has more shares outstanding
The number of shares outstanding for MYSE has been increased compared to 5 years ago.
MYSE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MYSE Yearly Shares OutstandingMYSE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
MYSE Yearly Total Debt VS Total AssetsMYSE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

Based on the Altman-Z score of -14.72, we must say that MYSE is in the distress zone and has some risk of bankruptcy.
MYSE has a worse Altman-Z score (-14.72) than 90.00% of its industry peers.
There is no outstanding debt for MYSE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -14.72
ROIC/WACCN/A
WACC11.29%
MYSE Yearly LT Debt VS Equity VS FCFMYSE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M 20M

2.3 Liquidity

MYSE has a Current Ratio of 8.98. This indicates that MYSE is financially healthy and has no problem in meeting its short term obligations.
MYSE has a better Current ratio (8.98) than 94.64% of its industry peers.
A Quick Ratio of 8.98 indicates that MYSE has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 8.98, MYSE belongs to the top of the industry, outperforming 94.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.98
Quick Ratio 8.98
MYSE Yearly Current Assets VS Current LiabilitesMYSE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 47.58% over the past year.
MYSE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -33.33%.
EPS 1Y (TTM)47.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.51%
Revenue 1Y (TTM)-33.33%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MYSE Yearly Revenue VS EstimatesMYSE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 10K 20K 30K 40K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MYSE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MYSE Price Earnings VS Forward Price EarningsMYSE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MYSE Per share dataMYSE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

MYSE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MYSEUM INC

NASDAQ:MYSE (9/3/2025, 3:34:31 PM)

1.858

-0.1 (-5.2%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.45%
Inst Owner ChangeN/A
Ins Owners3.48%
Ins Owner Change4.4%
Market Cap7.82M
AnalystsN/A
Price TargetN/A
Short Float %7.13%
Short Ratio2.2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 19555.45
P/FCF N/A
P/OCF N/A
P/B 0.85
P/tB 0.98
EV/EBITDA N/A
EPS(TTM)-1.35
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.1
FCFYN/A
OCF(TTM)-1.06
OCFYN/A
SpS0
BVpS2.19
TBVpS1.9
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -64.54%
ROE -52.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-100.23%
ROA(5y)-97.03%
ROE(3y)-98.69%
ROE(5y)-103.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.98
Quick Ratio 8.98
Altman-Z -14.72
F-Score3
WACC11.29%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%11.51%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-33.33%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y29.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y34.09%
OCF growth 3YN/A
OCF growth 5YN/A